Mendota Financial Group’s ICU Medical ICUI Stock Holding History

Mendota Financial Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$365	–	757
2024 Q3	$365	Buy	+2	New	+$296	﹤0.01%	439

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mendota Financial Group's ICUI Position: Q4 2024 in Review

Mendota Financial Group sold out of ICU Medical (ICUI) in Q4 2024, closing a stake of 2 shares — an estimated $365 sold.

Mendota Financial Group first reported a position in ICUI in Q3 2024 and held it in 1 quarter. The position peaked at $365 in Q3 2024. 286 funds tracked by Wall St. Rank hold ICUI as of Q4 2024.

Mendota Financial Group reported no remaining ICU Medical position as of Q4 2024 after selling out during the quarter.
Mendota Financial Group sold 2 ICU Medical shares in Q4 2024, an estimated $365.
Mendota Financial Group first reported a position in ICU Medical in Q3 2024 and held it in 1 quarter.
Mendota Financial Group's ICU Medical position peaked at $365 in Q3 2024.
286 funds tracked by Wall St. Rank held ICU Medical as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.